from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3177/-

LFCtreatmentdescriptionclass of inhibitor

0.097

Amikacinug/mL Amikacintranslation

0.470

Cap5-10ug/mL Capreomycintranslation

-0.246

Rox10-50 ug/mL Roxithromycintranslation

0.173

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.450

Rif0.2-5ug/mL Rifampicintranscription

0.021

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.157

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.935

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.469

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.805

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.197

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.234

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.132

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.160

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.392

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.579

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.075

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.993

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.162

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

2.759

Nigericin50 uM Nigericinrespiration

0.003

TRC10-150 ug/mL Triclosanrespiration

0.042

TRZ10-25 ug/mL Thioridazinerespiration

-0.364

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.523

menadione6-10 ug/mL Menadionerespiration

-0.145

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.203

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.432

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.280

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.666

NRP_1Non-replicating persistence stage 1dosRassociated

0.299

Amp0.2mg/mL AmpicillincellWall

-0.574

Cephalexin20-100 ug/mL CephalexincellWall

1.115

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.171

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.579

EMB10-20 ug/mL EthambutolcellWall

-0.989

Eta12-40 ug/mL EthionamidecellWall

-0.404

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.143

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.462

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.477

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.478

BZA0.12 mg/mL BenzamidearomaticAmides

-0.022

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.830

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.428

H2O24 mM hydrogen peroxideDNAdamaging

-0.255

Levo10 ug/mL LevofloxacinDNAdamaging

0.221

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.583

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.087

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.120

UVUV-irradiationDNAdamaging

4.007

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.909

Antimycin12.5-50 ug/mL Antimycin A?

-1.054

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.074

PA_110-50 ug/mL Antitubercular compound PA-1?

0.558

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.452

PA8240.2-2 ug/mL PA-824?

0.190

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.339

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.656

Verapamil50 uM Verapamil?

-0.826

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.096

methoxatin10-20 ug/mL Methoxatin?